Bharat Electron Q1 FY27 Earnings Call — Analysis (NSE: BEL)
BEL reports 25% YoY revenue growth in Q1 FY27 to ₹5,533 Cr amid lean order inflow; maintains FY27 guidance and expects QRSAM order by September.
The take
Q1FY27 Revenue from operations ₹5,533 Cr ( +25.3% YoY ) . New guidance — FY27 fy27 revenue growth and ebitda… 21% to 23% . New story: Large platform order pipeline .
Results
Revenue ₹5,533 Cr, +25.3% YoY; EBITDA margin 25.83%, down YoY on product mix; PAT ₹1,048 Cr, +8.2% YoY; order book ₹72,258 Cr as on 1 Jul 2026.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue from operations | ₹5,533 Cr | +25.3% | yoy · Q1FY27 · Q1FY27 vs Q1FY26 |
| EBITDA margin | 25.83% | none · Q1FY27 · Q1FY27 standalone | |
| Profit before tax | ₹1,403 Cr | +8.8% | yoy · Q1FY27 · Q1FY27 vs Q1FY26 |
| Profit after tax | ₹1,048 Cr | +8.2% | yoy · Q1FY27 · Q1FY27 vs Q1FY26 |
| EPS | ₹1.43 | +7.5% | yoy · Q1FY27 · Q1FY27 vs Q1FY26 |
| Order book | ₹72,258 Cr | point_in_time · as on 1st July 2026 | |
| Order inflow | ₹3,754 Cr | none · Q1FY27 · Q1FY27 |
Guidance
FY27 revenue growth guidance of 15% reiterated; order inflow target ₹55,000+ Cr including QRSAM, with conflicting margin guidance of 28% (CFO) vs 21-23% (CMD).
What management committed to
- Maximum by September we will get [QRSAM order], and I am still sticking to that. — Q2FY27
- We are definitely going to meet the guidance given about the order inflow for this year ... INR55,000 plus crores, including QRSAM. — INR55,000 plus crores, FY27
- Current year EBITDA margin guidance we have given of 28%, we remain at that. — 28%, FY27
- Revenue growth of 15%, EBITDA margin 21% to 23%. — 21% to 23%, FY27
- [FY27] revenue growth of 15%. — 15%, FY27
- More than INR2,200 crores R&D budget we have allocated for this year. — INR2,200 crores, FY27
- INR1,200 plus crores we are investing under capex. — INR1,200 plus crores, FY27
- This year we have given our internal guidance of around USD300 million we should definitely fetch [export orders]. — USD300 million, FY27
- Target to complete all these indigenization [of modules/sub-modules] in next 5 years ... zero import of any module, sub-module level thing. — zero import, FY31
- Shatrughat and Samaghat we may get in another 3 to 6 months timeline ... around INR9,000 plus crores. — around INR9,000 plus crores, Q3FY27
- Shakti Phase 4 project ... we are going to get in this financial year ... around INR2,000 crores. — around INR2,000 crores, FY27
- HAMMER project also, we are going to get in this financial year ... around INR2,500 plus crores. — around INR2,500 plus crores, FY27
Key themes
Order pipeline visibility and margin resilience
How the narrative shifted
- QRSAM procedural clearance: Management highlights that only CCS approval remains, with all technical inputs completed, and expects clearance by September.
- Large platform order pipeline: Several major orders (Shatrughat, Samaghat, Shakti, HAMMER, NGC/P75I) are in final approval stages, providing visibility for strong order inflow in FY27-28.
- Indigenization margin buffer: Management emphasizes indigenization drive to offset input cost inflation and sustain margins, targeting zero module imports in 5 years.
- Export growth ambitions: Exports seen as a key growth lever with $300M order target this year and 10% revenue share in 5 years; strong lead pipeline.
- Product mix-driven margin volatility: Quarterly EBITDA margins fluctuate due to product mix, but annual margin guidance remains intact.
- Wage revision cost absorption: Upcoming wage revision from Jan 2027 will be absorbed through revenue growth, keeping employee cost/revenue at ~12%, no margin pressure.
Operational commentary
- QRSAM order awaiting CCS approval; management expects clearance by September 2026 after all technical inputs submitted.
- Shatrughat and Samaghat orders (~₹9,000+ Cr) expected in 3-6 months; Shakti Phase 4 (~₹2,000 Cr) and HAMMER (~₹2,500+ Cr) expected in FY27.
- Export order book at $465 million; targeting $300 million order intake in FY27, with ambition to reach 10% of revenue from exports in 5 years.
- Indigenization drive aiming to eliminate import of modules/sub-modules within 5 years; separate indigenization policy to be released.
- AMCA program RFP submission deadline extended to 27 August 2026; BEL and L&T aligning final response.
- Counter-drone: focus on high-power laser/microwave DEW hard-kill systems; prototypes ready, export demos conducted, some domestic orders already supplied.
- Netra 2 program: Adani Defence emerged as L1 integrator; BEL to supply subsystems (radar, EW, data links) leveraging core strengths.
- LCA Tejas: BEL has supplied more LRUs than required; no risk of aircraft delays due to electronics; potential delivery schedule shifts would be immaterial (<1% of revenue).
- Employee cost to turnover expected to remain around 12% despite wage revision from Jan 2027, as revenue growth absorbs impact.
Analyst Q&A
Q. Why lean order inflow in Q1? QRSAM delay?
Last year Q1 had spillover from Q4; this year no backlog; QRSAM awaiting CCS clearance, expected by September. Full-year order inflow guidance maintained.
Q. EBITDA margin decline – product mix or input cost?
Due to product mix, not input cost; full-year EBITDA margin guidance of 28% maintained.
Q. Potential order sizes for future naval platforms (P17B, P80, NGD, etc.)?
Too early to predict; configuration and BQ finalisation still ongoing; clarity expected in about one year.
Q. Missile program pipeline over next 5 years?
Difficult to predict; strategic decision of Government of India; suggest asking Ministry or NSA.
Q. Wage revision impact on margins?
Provision from Jan-Mar '27; employee cost to turnover expected to remain ~12% as revenue growth absorbs the hike.
Research and educational content only. Not investment advice.